JV makes ‘stability timer’ logistics tech to protect cell and gene therapies
The US Patent and Trademark Office has granted a notice of allowance for ‘shelf life’ timer technology used to protect time-sensitive biologic materials in transit.
Archives for March 27, 2018
Hitachi Chemical inks Daiichi Sankyo regenerative meds deal
Daiichi Sankyo has selected CDMO Hitachi Chemical Therapeutics Solutions to make regenerative medicine for the Japanese market.
Takeda’s off-the-shelf stem cell therapy approved in Europe
Alofisel (darvadstrocel) has become the first allogeneic stem cell product to be approved in Europe.
Positively Europe: Thumbs up for Amgen, Sandoz biosimilars
The EMA has recommended the approvals of a third Herceptin (trastuzumab) biosimilar made by Amgen and Sandoz’s version of Remicade (infliximab).